Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D07AC01	BETNOVATE	B	Betamethasone - 0.1%	0.1%	Solution	235,172 L.L
J05AF07	VIREAD	B	Tenofovir disoproxil - 245mg	245mg	Tablet, film coated	15,716,313 L.L
N02BE51	PANADOL EXTRA WITH OPTIZORB	B	Paracetamol - 500mg, Caffeine - 65mg		Tablet, film coated	252,642 L.L
N06DA02	ARICEPT	B	Donepezil HCl - 5mg	5mg	Tablet, film coated	3,254,787 L.L
S01CA01	NETILDEX	B	Dexamethasone - 0.1%, Netilmicin - 0.3%		Drops solution	752,552 L.L
A10BG03	ACTOS	B	Pioglitazone HCl - 30mg	30mg	Tablet	2,484,765 L.L
C01EB15	VASTAREL	B	Trimetazidine - 35mg	35mg	Tablet, film coated, modified release	1,053,573 L.L
D07AC01	BETNOVATE	B	Betamethasone (valerate) - 0.1%	0.1% w/w	Cream	279,519 L.L
L04AX04	REVLIMID	B	Lenalidomide - 5mg	5mg	Capsule	105,106,076 L.L
M03BX	DORIXINA RELAX	B	Lysine clonixinate - 125mg, Cyclobenzaprine HCl - 5mg		Tablet, film coated	581,884 L.L
L01EX08	LENVIMA	B	Lenvatinib - 10mg	10mg	Capsule, hard	L.L
A06AX05	RESOLOR	B	Prucalopride succinate - 1mg	1mg	Tablet, film coated	3,273,600 L.L
G03GB02	CLOMID	B	Clomifene citrate - 50mg	50mg	Tablet	274,144 L.L
L01CD04	JEVTANA INJECTION	B	Cabazitaxel - 60mg/1.5ml	60mg/1.5ml	Injectable dry powder for solution+diluent	75,619,931 L.L
L01XA03	ELOXATIN	B	Oxaliplatin - 50mg/10ml	50mg/10ml	Injectable concentrated solution	4,930,558 L.L
L01EX08	LENVIMA	B	Lenvatinib - 4mg	4mg	Capsule, hard	L.L
A10BG03	ACTOS	B	Pioglitazone HCl - 15mg	15mg	Tablet	1,243,054 L.L
C01EB17	PROCORALAN	B	Ivabradin (HCl) - 5mg	5mg	Tablet, film coated	1,890,786 L.L
D07AC01	DIPROSONE	B	Betamethasone (dipropionate) - 0.5mg/g	0.05%	Cream	291,614 L.L
J01DI01	ZEVTERA	B	Ceftobiprole medocaril Sodium - 500mg	500mg	Injectable powder for concentrate for solution	47,129,773 L.L
L01CD04	JEVTANA INJECTION	B	Cabazitaxel - 60mg/1.5ml	60mg/1.5ml	Injectable dry powder for solution+diluent	75,619,931 L.L
S01EA05	ALPHAGAN P	B	Brimonidine tartrate - 1.5mg/ml	0.15%	Drops solution	999,819 L.L
B01AF01	XARELTO	B	Rivaroxaban - 20mg	20mg	Tablet, film coated	4,440,862 L.L
C09AA05	TRITACE	B	Ramipril - 10mg	10mg	Tablet	689,391 L.L
D07AC01	BETNOVATE	B	Betamethasone (valerate) - 0.1%	0.1% w/w	Ointment	279,519 L.L
M03BX02	SIRDALUD	B	Tizanidine HCl - 2mg	2mg	Tablet	680,450 L.L
N02BE51	123 COMPLETE	B	Acetaminophen (day tablet, night tablet) - 500mg, Dextromethorphan HBr (day tablet, night tablet) - 5mg, Phenylephrine HCl (day tablet, night tablet) - 5mg, Carbinoxamine maleate (night tablet) - 3mg		Tablet	537,537 L.L
S01EA05	ALPHAGAN P	B	Brimonidine tartrate - 1.5mg/ml	0.15%	Drops solution	999,819 L.L
G03HB01	DIANE '35'	B	Ethinylestradiol - 0.035mg, Cyproterone acetate - 2mg		Tablet	494,534 L.L
J01DI54	ZERBAXA	B	Ceftolozane Sulfate - 1g, Tazobactam (sodium) - 0.5g		Injectable powder for concentrate for solution	74,780,802 L.L